Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
CIZ.L
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.19
N/A
-0.00
vs NA
Q2.20
N/A
-0.00
vs -0.00
Q4.20
N/A
-0.00
vs -0.00
Q2.21
N/A
-0.01
vs -0.00
Q4.21
N/A
-0.00
vs -0.00
Q2.22
N/A
-0.00
vs -0.01
Q4.22
N/A
-0.00
vs -0.00
Q2.23
N/A
-0.00
vs -0.00
Q4.23
+100%
NA
vs -0.00
Q2.24
+100%
NA
vs -0.00
Sales Growth
YoY
Current
Estimates
Q4.19
-100%
-12.50 vs 37K
Q2.20
-100%
NA vs 12.5
Q4.20
+100%
NA vs -12.5
Q2.21
NA
NA vs NA
Q4.21
NA
NA vs NA
Q2.22
NA
NA vs NA
Q4.22
NA
NA vs NA
Q2.23
NA
NA vs NA
Q4.23
NA
NA vs NA
Q2.24
NA
NA vs NA
Return on Equity
QoQ
Q4.20
-484%
-4.84
vs -0.08
Q2.21
-245%
-2.45
vs -4.84
Q4.21
-73%
-0.73
vs -2.45
Q2.22
-16%
-0.16
vs -0.73
Q4.22
-20%
-0.20
vs -0.16
Q2.23
0%
-0.00
vs -0.20
Q4.23
0%
-0.00
vs -0.00
Q2.24
0%
-0.00
vs -0.00
Institutionnal Ownership
Relative Strength
CIZ.L
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
LSE
Unprofitable
EPS improving
Unprofitable
EPS improving
-0.05Â ( -3.23%)
Relative Strenght
Volume Buzz
94%
Earning Acce
No
Dist 52w H.
44%Forecast
NaN%2024-EPS
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How CIZ.L compares to sector?